Home ›
NPI 1598771214
NPI deactivated
1598771214
1598771214 was paid $131K by Medicaid between Mar 2019 and Mar 2021, across 27 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider info1598771214
33aNPI1598771214
33bProvider type—
28Total paid$131K
24GClaims8,059
24DCodes billed27
24AFirst – last monthMar 2019 – Mar 2021
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 2,136 | $40K | |
| 2020 | 5,232 | $80K | |
| 2021 | 691 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 1,238 | 824 | $66K |
| 20552 | 31% | 953 | 623 | $40K | |
| 27096 | 10% | 56 | 30 | $13K | |
| 62323 | 3.6% | 43 | 26 | $5K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.1% | 28 | 20 | $1K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 14 | 13 | $1K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 406 | 282 | $711.84 |
| 72190 | <1% | 34 | 26 | $674.86 | |
| 20610 | <1% | 20 | 17 | $588.84 | |
| 20550 | <1% | 33 | 20 | $520.79 | |
| 72070 | <1% | 18 | 14 | $336.68 | |
| 72100 | <1% | 16 | 15 | $330.33 |
15 more codes
| 73030 | <1% | 20 | $298.85 | |
| 73502 | <1% | 21 | $239.10 | |
| 72200 | <1% | 21 | $156.10 | |
| 72120 | <1% | 17 | $128.56 | |
| L1833 | Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf | <1% | 32 | $113.90 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 224 | $96.50 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 197 | $49.16 |
| L2810 | Addition to lower extremity orthosis, knee control, condylar pad | <1% | 32 | $29.26 |
| 1123F | <1% | 1,269 | $0.16 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 1,270 | $0.12 |
| 1036F | <1% | 860 | $0.12 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 342 | $0.10 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | <1% | 672 | $0.02 |
| 1034F | <1% | 189 | $0.02 | |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.